Head and Neck Squamous Cell Carcinoma (HNSCC) Recruiting Phase Trials for DB00497 (Oxycodone)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02531906Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During ChemoradiationSupportive Care